Sticking to a daily medication routine is tough, especially when you're managing a chronic condition for the long haul. A major review of 52 studies asked whether digital helpers—like smartphone apps, text message reminders, and web platforms—could make that daily task easier for adults with chronic diseases. The analysis found these technologies do provide a statistically significant, though modest, benefit in helping people take their medications as prescribed. The overall effect was small-to-moderate, but the story gets more interesting when you look closer. The benefit wasn't consistent everywhere; it varied dramatically from country to country, and medium-duration programs seemed to work best. The researchers also noted a high level of variation among the studies they analyzed, which makes it hard to pin down one clear answer. They also found signs that studies with positive results might be more likely to get published, which could mean the true benefit is slightly higher than their main calculation showed. So, while this review suggests digital nudges can help, it also highlights that their effectiveness depends heavily on the specific context—what works in one place or for one group might not work as well elsewhere.
Digital self-management technologies show small-to-moderate benefit for medication adherence in chronic diseaseCan apps and texts help people stick to their medications? A review finds modest benefits
AI-generated summary of the cited source, checked by automated accuracy review. How we work
A systematic review and meta-analysis pooled data from 52 studies involving adults with various chronic diseases to assess the effectiveness of digital self-management technologies—including mobile health apps, SMS reminders, and web-based platforms—on medication adherence. The comparator was standard care or other control groups, though specifics were not reported. The pooled random-effects analysis showed a statistically significant, small-to-moderate benefit, with an effect size of Cohen's d = 0.268 (95% CI 0.123-0.414, p = 0.0003). Effects were largest for medium-duration interventions (d = 0.50) and varied markedly by country, ranging from d = 2.29 in Iran to d = -0.94 in Taiwan. A trim-and-fill adjustment for potential publication bias increased the pooled effect to d = 0.366.
Safety and tolerability data were not reported across the included studies. The analysis has important limitations, including high statistical heterogeneity (I² = 89%), which suggests substantial variation in true effects across studies, and possible publication bias as indicated by Begg's test. The evidence base included RCTs, quasi-experimental, and controlled before-after studies, establishing an association but not definitive causality.
For practice, this meta-analysis indicates that digital self-management tools can be associated with improved medication adherence in chronic disease populations, but the effect is modest and highly context-dependent. The significant variation by geography and intervention characteristics underscores that these technologies are not uniformly effective. Clinicians should consider local evidence and patient preferences when recommending specific digital tools, recognizing that the overall evidence strength is tempered by heterogeneity and potential bias.